Stockreport

Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026

Definium Therapeutics, Inc. - Common Shares  (DFTX) 
PDF NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics in [Read more]